rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Aethlon Medical, Inc.

AEMD · Nasdaq

Health CareMedical DevicesNot moving yet

AEMD stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 24.0% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
29% -5 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
17 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

21 Apr – 20 Oct
19%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders17+4 on the quarter
New · exited7 · 3
Reported value$136K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCnew · filed 14 Aug 202642,977$35K+42,977
JANE STREET GROUP, LLCnew · filed 14 Aug 202638,880$32K+38,880
Shay Capital LLCadded · filed 14 Aug 202631,072$26K+16,948+120.0%
Ikarian Capital, LLCunchanged · filed 14 Aug 202614,364$12K00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202610,189$8,389-14,175−58.2%
Scientech Research LLCnew · filed 14 Aug 202610,054$8,278+10,054
UBS Group AGadded · filed 13 Aug 20268,876$7,305+7,981+891.7%
Tower Research Capital LLC (TRC)added · filed 11 Aug 20266,331$5,213+4,720+293.0%
MORGAN STANLEYadded · filed 13 Aug 20262,472$2,035+425+20.8%
JONES FINANCIAL COMPANIES LLLPnew · filed 14 Aug 202617$15+17
31 Dec 2023 – 30 Jun 2026
112130Dec 23Sep 24Mar 25Dec 25Jun 26

Everyone who traded it

James B. Frakes Company insiderCFO/CEO · last 8 Oct 20260 · 0
Steven P. Larosa Company insiderChief Medical Officer · last 8 Oct 20260 · 0
Chetan Shah Company insiderDirector · last 30 Sep 20260 · 1
Edward G. Broenniman Company insiderDirector · last 30 Sep 20260 · 25
Nicolas Gikakis Company insiderDirector · last 30 Sep 20260 · 0
Angela Rossetti Company insiderDirector · last 17 Apr 20260 · 0
Lee D. Arnold Company insiderChief Scientific Officer · last 1 Feb 20230 · 0
Sabrina Martucci Johnson Company insiderDirector · last 31 Mar 20220 · 0
Charles J. Fisher, Jr. Company insiderChief Executive Officer · last 10 Feb 20220 · 0
Guy F. Cipriani Company insiderSr. V.P., Chief Bus. Officer · last 10 Feb 20220 · 0
Timothy C. Rodell, Jr. Company insiderChief Executive Officer · last 3 Apr 20200 · 0
James A. Joyce Company insiderChairman, CEO, Secretary · last 31 Oct 20180 · 0

Same industry

RCEL Avita MedicalLeading+108%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+52%
HAE HaemoneticsLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2026 · to 31 Mar 2026-149%
Share count trendFY 2026 · to 8 Jun 202650.9%
Cash and equivalentsFY 2026 · to 31 Mar 2026$5.0M
Free cash flowFY 2026 · to 31 Mar 2026−$7.0M

Analyst forecasts

No analyst forecasts yet.